n-methyl-3,4-methylenedioxyamphetamine and methylphenidate

n-methyl-3,4-methylenedioxyamphetamine has been researched along with methylphenidate in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.00)18.2507
2000's8 (32.00)29.6817
2010's13 (52.00)24.3611
2020's3 (12.00)2.80

Authors

AuthorsStudies
Durst, R; Rebaudengo-Rosca, P1
Achat-Mendes, C; Anderson, KL; Itzhak, Y1
Kishimoto, H1
Kuypers, KP; Ramaekers, JG1
Kuypers, KP; Ramaekers, JG; Samyn, N1
Ikeda, K; Iwamura, T; Kobayashi, T; Nishizawa, D1
Fahey, MA; Fryer, AK; Lynch, L; Madras, BK; Miller, GM; Verrico, CD1
Collier, TJ; Lipton, JW; Lynch, KA; Paumier, KL; Pei, L; Sortwell, CE; Terpstra, BT; Thompson, VB; Tolod, EG1
Cerutti, DT; Galizio, M; McKinney, P; Pitts, RC1
Arrant, AE; Caster, JM; Kuhn, CM; Morris, SE; Nagel, JM; Parylak, S; Walker, QD; Zhou, G1
Atkins, KD; Dafny, N; Yang, PB1
Costa, G; Fenu, S; Morelli, M; Pinna, A; Plumitallo, A; Simola, N1
Donzelli, M; Grouzmann, E; Hysek, CM; Liechti, ME; Meyer, N; Schillinger, N; Schmid, Y; Simmler, LD1
Hysek, CM; Kratschmar, DV; Liechti, ME; Odermatt, A; Penno, CA; Schmid, Y; Seibert, J1
Higashiyama, K; Kazawa, H; Mochizuki, A; Mori, T; Shibasaki, M; Suzuki, T; Uzawa, N; Watanabe, H; Yoshizawa, K1
Crockett, MJ; Hysek, CM; Liechti, ME; Quednow, BB; Schmid, Y; Simmler, LD1
Bilderbeck, AC; Bosch, OG; Hysek, CM; Liechti, ME; Preller, KH; Quednow, BB; Rogers, RD; Schmid, Y1
Eggleston, W; Stork, C1
Borgwardt, S; Dolder, PC; Liechti, ME; Müller, F; Schmid, Y; Schmidt, A; Zanchi, D1
Borgwardt, SJ; Dolder, PC; Liechti, ME; Müller, F; Schmid, Y1
Borgwardt, S; Dolder, PC; Egloff, L; Liechti, ME; Müller, F; Schmid, Y; Schmidt, A; Zanchi, D1
Johansen, SS; Linnet, K; Nedahl, M1
Hirayama, S; Hokazono, M; Iwase, Y; Masukawa, D; Mori, T; Suzuki, T; Udagawa, Y; Uzawa, N1
Daviskiba, S; Dean, D; Kern, P; King, A; Reed, B; Rockhill, S; Vohra, V1
Baumgartner, MR; Fischer, SKM; Müller, TJ; Mutschler, J; Perlov, E; Seifritz, E; Soyka, M; Tschudi, L1

Reviews

2 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and methylphenidate

ArticleYear
[Stimulant dependence].
    Ryoikibetsu shokogun shirizu, 2003, Issue:40

    Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Humans; Methamphetamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Self-Help Groups; Social Support

2003
Generation Z: Adolescent Xenobiotic Abuse in the 21st Century.
    Adolescent medicine: state of the art reviews, 2015, Volume: 26, Issue:3

    Topics: Adolescent; Amphetamine-Related Disorders; Cannabinoids; Central Nervous System Stimulants; Designer Drugs; Dextroamphetamine; Dextromethorphan; Excitatory Amino Acid Antagonists; Hallucinogens; Humans; Inhalant Abuse; Ketamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine Abuse; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders; Xenobiotics

2015

Trials

9 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and methylphenidate

ArticleYear
Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:6

    Topics: Adult; Affect; Amphetamine-Related Disorders; Cross-Over Studies; Discrimination Learning; Double-Blind Method; Female; Humans; Male; Memory; Memory, Short-Term; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Pattern Recognition, Visual; Problem Solving; Retention, Psychology; Substance Withdrawal Syndrome; Verbal Learning

2005
Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
    Addiction (Abingdon, England), 2006, Volume: 101, Issue:11

    Topics: Adult; Amphetamine-Related Disorders; Automobile Driving; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Hallucinogens; Humans; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine

2006
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:3

    Topics: Adult; Affect; Area Under Curve; Autonomic Nervous System; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Endocrine System; Female; Hallucinogens; Humans; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Young Adult

2014
Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.
    Neuroendocrinology, 2014, Volume: 100, Issue:1

    Topics: Chromatography, Liquid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Steroids; Tandem Mass Spectrometry; Time Factors; Young Adult

2014
Differential effects of MDMA and methylphenidate on social cognition.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Empathy; Epinephrine; Facial Expression; Female; Hallucinogens; Humans; Hydrocortisone; Judgment; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin; Prolactin; Recognition, Psychology; Young Adult

2014
Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Female; Hallucinogens; Humans; Interpersonal Relations; Libido; Male; Methylphenidate; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Progesterone; Sexual Behavior; Testosterone; Time Factors; Young Adult

2015
Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
    The international journal of neuropsychopharmacology, 2017, 09-01, Volume: 20, Issue:9

    Topics: Benzhydryl Compounds; Brain; Brain Mapping; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Double-Blind Method; Emotions; Female; Hallucinogens; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Neural Pathways; Oxygen; Psychometrics

2017
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
    Psychopharmacology, 2018, Volume: 235, Issue:2

    Topics: Adult; Arousal; Autonomic Nervous System; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Emotions; Facial Recognition; Female; Hallucinogens; Healthy Volunteers; Humans; Libido; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Sexual Behavior; Young Adult

2018
Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.
    The international journal of neuropsychopharmacology, 2018, 04-01, Volume: 21, Issue:4

    Topics: Adult; Brain; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Facial Expression; Facial Recognition; Fear; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Young Adult

2018

Other Studies

14 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and methylphenidate

ArticleYear
[Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Harefuah, 1997, May-01, Volume: 132, Issue:9

    Topics: Adult; Alcoholism; Attention Deficit Disorder with Hyperactivity; Cannabis; Central Nervous System Stimulants; Female; Humans; Lysergic Acid Diethylamide; Marijuana Abuse; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

1997
Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood.
    Neuropharmacology, 2003, Volume: 45, Issue:1

    Topics: Age Factors; Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Psychological; Male; Methylphenidate; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Reward; Substance Withdrawal Syndrome; Time Factors; Weight Gain

2003
Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
    Toxicology in vitro : an international journal published in association with BIBRA, 2007, Volume: 21, Issue:4

    Topics: Animals; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; Electrophysiology; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart; Methamphetamine; Methylphenidate; Mice; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Plasmids; Potassium Channel Blockers; RNA, Messenger; Xenopus laevis

2007
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:2

    Topics: Administration, Oral; Animals; Appetitive Behavior; Association Learning; Cell Line; Citalopram; Desipramine; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Injections, Intramuscular; Macaca fascicularis; Male; Mental Recall; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Reversal Learning; Serotonin Plasma Membrane Transport Proteins; Stereotyped Behavior

2008
3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.
    Neuropharmacology, 2008, Volume: 55, Issue:5

    Topics: Analysis of Variance; Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Gene Expression Regulation; Hallucinogens; In Vitro Techniques; Male; Mesencephalon; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Neurites; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase

2008
Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 94, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Male; Methamphetamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule; Time Factors

2009
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: Aging; Amphetamines; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Electrophysiology; Male; Methylphenidate; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nomifensine; Piperazines; Rats; Rats, Sprague-Dawley

2010
Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats.
    European journal of pharmacology, 2011, Jul-01, Volume: 661, Issue:1-3

    Topics: Animals; Behavior, Animal; Drug Interactions; Drug Tolerance; Female; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Time Factors

2011
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward.
    Neuropharmacology, 2012, Volume: 63, Issue:2

    Topics: Animals; Central Nervous System Stimulants; Male; Methylphenidate; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Reward; Vocalization, Animal

2012
Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 350, Issue:2

    Topics: Animals; Benzazepines; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Receptors, sigma; Sigma-1 Receptor

2014
Postmortem Brain-Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate.
    Journal of analytical toxicology, 2019, Jun-01, Volume: 43, Issue:5

    Topics: Amphetamine; Autopsy; Brain Chemistry; Calibration; Cocaine; Forensic Toxicology; Gray Matter; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Postmortem Changes; Reference Standards; Reproducibility of Results

2019
Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.
    Behavioural brain research, 2021, 01-01, Volume: 396

    Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Gyrus Cinguli; Male; Methamphetamine; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Orexins; Reward; Serotonin 5-HT1 Receptor Agonists; Spatial Learning

2021
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
    Clinical toxicology (Philadelphia, Pa.), 2021, Volume: 59, Issue:8

    Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Drug Overdose; Female; Humans; Linear Models; Male; Methamphetamine; Methylphenidate; Michigan; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Poison Control Centers

2021
Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
    European addiction research, 2023, Volume: 29, Issue:5

    Topics: Amphetamine; Analgesics, Opioid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cross-Sectional Studies; Heroin; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Treatment Outcome

2023